These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10023645)

  • 1. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
    Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
    Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ascitic level of hyaluronan in liver cirrhosis.
    Lai KN; Szeto CC; Lam CW; Lai KB; Wong TY; Leung JC
    J Lab Clin Med; 1998 Apr; 131(4):354-9. PubMed ID: 9579389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
    Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis.
    Szeto CC; Wong TY; Lai KB; Lam CW; Lai KN; Li PK
    Am J Kidney Dis; 2000 Sep; 36(3):609-14. PubMed ID: 10977794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis.
    Breborowicz A; Wisniewska J; Polubinska A; Wieczorowska-Tobis K; Martis L; Oreopoulos DG
    Perit Dial Int; 1998; 18(4):382-6. PubMed ID: 10505559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
    Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
    Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD.
    Yung S; Coles GA; Davies M
    Kidney Int; 1996 Oct; 50(4):1337-43. PubMed ID: 8887296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
    Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
    Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA.
    Witowski J; Jörres A; Coles GA; Williams JD; Topley N
    Kidney Int; 1996 Oct; 50(4):1212-23. PubMed ID: 8887280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a high peritoneal transport rate reflect a state of chronic inflammation?
    Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
    Perit Dial Int; 1999; 19(1):17-22. PubMed ID: 10201336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
    Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
    Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The source and possible significance of hyaluronan in the peritoneal cavity.
    Yung S; Coles GA; Williams JD; Davies M
    Kidney Int; 1994 Aug; 46(2):527-33. PubMed ID: 7967367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients.
    Yamagata K; Tomida C; Koyama A
    Perit Dial Int; 1999; 19(2):131-7. PubMed ID: 10357183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
    Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ
    Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of peritoneal membrane function in continuous ambulatory peritoneal dialysis: relationship with peritonitis and fibrosing factors.
    Wong TY; Szeto CC; Lai KB; Lam CW; Lai KN; Li PK
    Perit Dial Int; 2000; 20(6):679-85. PubMed ID: 11216559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A; Fernando RL; Varghese Z
    Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse MCP-1/IL-8 ratio in effluents of CAPD patients with peritonitis and in isolated cultured human peritoneal macrophages.
    Sach M; Bauermeister K; Burger JA; Loetscher P; Elsner J; Schollmeyer P; Dobos GJ
    Nephrol Dial Transplant; 1997 Feb; 12(2):315-20. PubMed ID: 9132652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1.
    Brauner A; Hertting O; Alkstrand E; Sandberg E; Chromek M; Chen ZW; Ostenson CG
    Perit Dial Int; 2003; 23(1):5-13. PubMed ID: 12691501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.